The role of entrepreneurial decision-making in opportunity creation and recognition
暂无分享,去创建一个
[1] V. Chiesa,et al. Organisational modes for Open Innovation in the bio-pharmaceutical industry: An exploratory analysis , 2011 .
[2] P. Soh. The role of networking alliances in information acquisition and its implications for new product performance , 2003 .
[3] Waverly W. Ding,et al. Divergent paths to commercial science: A comparison of scientists' founding and advising activities , 2011 .
[4] Saras D. Sarasvathy,et al. Knowing What to Do and Doing What You Know , 2005 .
[5] Jay B. Barney,et al. Discovery and creation: alternative theories of entrepreneurial action , 2007 .
[6] William B. Gartner,et al. A Conceptual Framework for Describing the Phenomenon of New Venture Creation , 1985 .
[7] E. Garnsey,et al. Commercializing Generic Technology: The Case of Advanced Materials Ventures , 2005 .
[8] A. McGahan,et al. Business-Model Innovation: General Purpose Technologies and their Implications for Industry Structure , 2010 .
[9] H. Etzkowitz. The norms of entrepreneurial science: cognitive effects of the new university-industry linkages , 1998 .
[10] S. Sarasvathy. Causation and Effectuation: Toward a Theoretical Shift from Economic Inevitability to Entrepreneurial Contingency , 2001 .
[11] Gary P. Pisano,et al. The Evolution of Science-Based Business: Innovating How We Innovate , 2010 .
[12] Amalya L. Oliver,et al. Social Networks, Learning, and Flexibility: Sourcing Scientific Knowledge in New Biotechnology Firms , 1994 .
[13] Annapoornima M. Subramanian,et al. When birds of a feather don’t flock together: Different scientists and the roles they play in biotech R&D alliances , 2013 .
[14] M. Fontes. The process of transformation of scientific and technological knowledge into economic value conducted by biotechnology spin-offs , 2005 .
[15] E. Garnsey,et al. Process-based vs. product-based innovation: Value creation by nanotech ventures , 2012 .
[16] Margarida Fontes,et al. The commercialisation decisions of research-based spin-off: Targeting the market for technologies , 2012 .
[17] J. DiMasi,et al. Success rates for new drugs entering clinical testing in the United States , 1995, Clinical pharmacology and therapeutics.
[18] Andy Neely,et al. Inventors and Entrepreneurs in Academia: What Types of Skills and Experience Matter? , 2011 .
[19] D. Shepherd. Multilevel Entrepreneurship Research: Opportunities for Studying Entrepreneurial Decision Making , 2011 .
[20] S. Shane,et al. The Promise of Entrepreneurship as a Field of Research , 2000 .
[21] Elizabeth Garnsey,et al. Developmental conditions of UK biopharmaceutical ventures , 2003 .
[22] W. Powell,et al. Interorganizational Collaboration and the Locus of Innovation: Networks of Learning in Biotechnology. , 1996 .
[23] Trudie Aberdeen. Yin, R. K. (2009). Case study research: Design and methods (4th Ed.). Thousand Oaks, CA: Sage. , 2013, The Canadian Journal of Action Research.
[24] G. Pisano. Can science be a business? Lessons from biotech. , 2006, Harvard business review.
[25] James M. Utterback,et al. Radical Innovation from the Confluence of Technologies: Innovation Management Strategies for the Emerging Nanobiotechnology Industry , 2014 .
[26] S. Shane. A General Theory of Entrepreneurship , 2003 .
[27] Todd R. Zenger,et al. Opportunity Discovery, Problem Solving and a Theory of the Entrepreneurial Firm , 2007 .
[28] Richard N. Cardozo,et al. A theory of entrepreneurial opportunity identification and development , 2003 .
[29] Stuart A Read,et al. Effectual versus predictive logics in entrepreneurial decision-making: Differences between experts and novices , 2009 .
[30] R. Yin. Case Study Research: Design and Methods , 1984 .
[31] Lowell W. Busenitz,et al. Toward a Theory of Entrepreneurial Cognition: Rethinking the People Side of Entrepreneurship Research , 2002 .
[32] R. W. Hansen,et al. The price of innovation: new estimates of drug development costs. , 2003, Journal of health economics.
[33] J. Vernon,et al. Financial risk of the Biotech Industry versus the Pharmaceutical Industry , 2009 .
[34] Gerard George,et al. Academics or entrepreneurs? Investigating role identity modification of university scientists involved in commercialization activity , 2009 .
[35] P. Wong,et al. Entrepreneurial Resource Acquisition through Indirect Ties: Compensatory Effects of Prior Knowledge , 2010 .
[36] Rita Gunther McGrath. Business Models: A Discovery Driven Approach , 2010 .
[37] R. Yin,et al. Case Study Research: Design and Methods (4th ed. , 2009 .
[38] A. M. Subramanian,et al. When do firms benefit from university–industry R&D collaborations? The implications of firm R&D focus on scientific research and technological recombination , 2014 .
[39] H. Chesbrough. Business Model Innovation: Opportunities and Barriers , 2010 .
[40] Israel M. Kirzner. Entrepreneurial Discovery and the Competitive Market Process: An Austrian Approach , 1997 .
[41] David H. Hsu. Experienced entrepreneurial founders, organizational capital, and venture capital funding , 2007 .
[42] Nicholas Dew,et al. What to Do Next? The Case for Non-Predictive Strategy , 2006 .
[43] Kathleen M. Eisenhardt,et al. Theory Building From Cases: Opportunities And Challenges , 2007 .
[44] K. J. Samsom. A longitudinal study of success and failure among scientist-started ventures , 2010 .
[45] Salih Zeki Ozdemir,et al. Vertical alliance networks: The case of university–biotechnology–pharmaceutical alliance chains , 2007 .
[46] J. Niosi. Alliances are not enough explaining rapid growth in biotechnology firms , 2003 .
[47] R. Baron. Opportunity Recognition as Pattern Recognition: How Entrepreneurs “Connect the Dots” to Identify New Business Opportunities , 2006 .
[48] S. Shane. Prior Knowledge and the Discovery of Entrepreneurial Opportunities , 2000 .
[49] L. Willemstein,et al. Dynamics in business models: An empirical analysis of medical biotechnology firms in the Netherlands , 2007 .
[50] Troy V. Mumford,et al. Causation and effectuation processes: A validation study , 2011 .
[51] Jianzhen Xu,et al. Connect the dots , 2013, Autophagy.
[52] A. Bhide. The Origin and Evolution of New Businesses , 2000 .
[53] Nicholas Dew,et al. New market creation through transformation , 2005 .
[54] James C Greenwood,et al. Biotechnology: Delivering on the Promise , 2010, Science Translational Medicine.
[55] Jeffery S. McMullen,et al. Entrepreneurial Action And The Role Of Uncertainty In The Theory Of The Entrepreneur , 2006 .
[56] Elizabeth Garnsey,et al. A Theory of the Early Growth of the Firm , 1998 .
[57] Alice Lam,et al. What motivates academic scientists to engage in research commercialization: ‘Gold’, ‘ribbon’ or ‘puzzle’? , 2011 .
[58] Josep Samitier,et al. Market challenges facing academic research in commercializing nano-enabled implantable devices for in-vivo biomedical analysis , 2012 .
[59] Roberto Fontana,et al. The Impact of Academic Patenting on University Research and Its Transfer , 2009 .
[60] John T. Perry,et al. Entrepreneurial Effectuation: A Review and Suggestions for Future Research , 2012 .